from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1541c/lprI

LFCtreatmentdescriptionclass of inhibitor

1.183

Amikacinug/mL Amikacintranslation

0.931

Cap5-10ug/mL Capreomycintranslation

0.625

Rox10-50 ug/mL Roxithromycintranslation

0.178

SM2-5 ug/mL Streptomycintranslation

0.326

Tet5-10 ug/mL Tetracyclinetranslation

-0.398

Rif0.2-5ug/mL Rifampicintranscription

0.081

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.819

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.551

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.024

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.792

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.117

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.511

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.816

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.372

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.630

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.750

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.235

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.552

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.559

KCN5-20 ug/mL Potassium cyaniderespiration

-0.658

NaN30.2-2 mM Sodium aziderespiration

-0.677

Nigericin50 uM Nigericinrespiration

0.405

TRC10-150 ug/mL Triclosanrespiration

-0.657

TRZ10-25 ug/mL Thioridazinerespiration

-2.043

Valinomycin0.5-10 uM Valinomycinrespiration

-0.799

ZnSO42 mM ZnSO4respiration

-0.549

menadione6-10 ug/mL Menadionerespiration

-0.603

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.279

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.227

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.048

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.016

NRP_1Non-replicating persistence stage 1dosRassociated

0.323

Amp0.2mg/mL AmpicillincellWall

1.169

Cephalexin20-100 ug/mL CephalexincellWall

0.534

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.455

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.209

EMB10-20 ug/mL EthambutolcellWall

0.617

Eta12-40 ug/mL EthionamidecellWall

0.526

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.029

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.517

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.706

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.557

BZA0.12 mg/mL BenzamidearomaticAmides

0.276

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.024

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.073

H2O24 mM hydrogen peroxideDNAdamaging

0.856

Levo10 ug/mL LevofloxacinDNAdamaging

-0.356

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.127

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.320

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.185

UVUV-irradiationDNAdamaging

-0.336

ARP41-4 ug/mL Antitubercular compound ARP4?

0.031

Antimycin12.5-50 ug/mL Antimycin A?

0.653

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.062

PA_110-50 ug/mL Antitubercular compound PA-1?

0.228

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.558

PA8240.2-2 ug/mL PA-824?

0.131

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.269

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.054

Verapamil50 uM Verapamil?

0.407

mercaptoethanol2 mM 2-Mercaptoethanol?

1.148

methoxatin10-20 ug/mL Methoxatin?